Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Predictive Oncology Inc. Director's Dealing 2023

Oct 4, 2023

35106_dirs_2023-10-04_b9fe71e1-4007-411c-8032-fc5cfe834f5c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Predictive Oncology Inc. (POAI)
CIK: 0001446159
Period of Report: 2023-10-02

Reporting Person: Rao Veena (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-10-02 Common Stock A 1875 Acquired 5849 Direct